2021
Hepatocellular Carcinoma
Jain A, Mazer B, Deng Y, Ciarleglio M, Jain D, Taddei T, Zhang X. Hepatocellular Carcinoma. American Journal Of Clinical Pathology 2021, 157: 305-313. PMID: 34542582, DOI: 10.1093/ajcp/aqab125.Peer-Reviewed Original ResearchConceptsAnaplastic tumor cellsHepatocellular carcinomaNoncirrhotic liverVascular invasionHistologic patternCirrhotic liverTumor cellsClear cell subtypePathogenesis of HCCHigh histologic gradeLarger tumor sizeHigher tumor stageHigh tumor gradeHigh rateHepatitis BHepatitis CLiver diseaseTumor sizeHistologic gradeTumor stageTumor gradePathologic differencesHCC casesRetrospective analysisPathology archives
2020
Splenic-vasculature involvement is associated with poor prognosis in resected distal pancreatic cancer
Yin F, Saad M, Lin J, Jackson CR, Ren B, Lawson C, Karamchandani DM, Bernabeu BQ, Jiang W, Dhir T, Zheng R, Schultz CW, Zhang D, Thomas CL, Zhang X, Lai J, Schild M, Zhang X, Xie H, Liu X. Splenic-vasculature involvement is associated with poor prognosis in resected distal pancreatic cancer. Gastroenterology Report 2020, 9: 139-145. PMID: 34026221, PMCID: PMC8128010, DOI: 10.1093/gastro/goaa084.Peer-Reviewed Original ResearchProgression-free survivalLarger tumor sizeOverall survivalStage pT3Radiographic evidencePrognostic valueTumor sizePancreatic cancerPancreatic carcinomaPredictors of PFSPost-operative adjuvant chemotherapyShorter progression-free survivalDistal pancreatic cancerSplenic artery invasionSplenic vein invasionIndependent risk factorPapillary mucinous neoplasmAdjuvant chemotherapyLymphovascular invasionNodal metastasisVein involvementDistant metastasisPerineural invasionPoor prognosisRetrospective study